KI-Beratung Beta

Produktbild: Smart Biosensing Technologies for Early Detection of Metabolic Disorders

Smart Biosensing Technologies for Early Detection of Metabolic Disorders

217,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Smart Biosensing Technologies for Early Detection of Metabolic Disorders gives a clear overview of the latest biosensor tools that help detect and monitor metabolic diseases like diabetes, obesity, and insulin resistance early. It explains how these sensors work using basic science and shows new wearable,...

Beschreibung

Smart Biosensing Technologies for Early Detection of Metabolic Disorders gives a clear overview of the latest biosensor tools that help detect and monitor metabolic diseases like diabetes, obesity, and insulin resistance early. It explains how these sensors work using basic science and shows new wearable, non-invasive, and easy-to-use devices. This book is useful for researchers, doctors, and professionals working in healthcare technology. This book connects research from different fields to help solve real problems in making and using biosensors. It includes examples of how these sensors are used, new markers for disease detection, and how AI and digital health can improve care. Readers will learn how to develop better diagnostic tools and improve treatment for metabolic diseases.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

13.08.2026

Verlag Elsevier
Seitenzahl

760

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

13.08.2026

Verlag Elsevier
Seitenzahl

760

Maße (L/B/H)

27,5/21,3/3,8 cm

Gewicht

450 g

Sprache

Englisch

ISBN

978-0-443-45911-5

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Weitere Artikel finden Sie in

  • Produktbild: Smart Biosensing Technologies for Early Detection of Metabolic Disorders
  • Section I: Foundations of biosensing and metabolic disorders
    1. Detecting the preclinical window in metabolic disorders: Biomarkers, biosensors, diagnostic challenges, and translational opportunities
    2. Multi-omic biomarkers and biosensors for metabolic disorders: Discovery to clinical translation
    3. Metabolic biosensing technologies: Biophysical foundations, transduction strategies, and clinical translation

    Section II: Emerging biosensing platforms for biomarker detection
    4. Nanomaterials for metabolic biosensing: Interfacial biophysics, analytical performance, and clinical translation
    5. Microfluidic and paper-based biosensing technologies for metabolic disorders: From sample processing to clinical translation
    6. Wearable optical and electrochemical biosensors for continuous metabolic monitoring: Principles, system integration, and clinical translation

    Section III: Smart and intelligent biosensing approaches
    7. Artificial intelligence and machine learning for metabolic biosensors: From data analytics to clinical deployment
    8. Cloud-edge architectures for connected metabolic care: IoMT integration, interoperability, analytics, and lifecycle management
    9. Continuous wearable and implantable biosensors for metabolic disorders: From biosensing technologies to clinical translation

    Section IV: Applications in early detection of specific metabolic disorders
    10. Smart biosensing technologies for diabetes mellitus: From biomarker discovery and sensor design to clinical validation and real-world deployment
    11. Multimodal biosensing and continuous phenotyping for obesity and metabolic syndrome: Biomarkers, sensor systems, and clinical translation
    12. Translational cardiometabolic biosensing integrating biomarkers, multiplex panels, sensing strategies, and clinical validation
    13. Multi-omic biomarkers, biosensing technologies, and precision diagnostics for rare and inherited metabolic disorders
    14. Advanced biophysical biosensing strategies for monitoring oxidative stress and inflammation in metabolic disorders

    Section V: Translational perspectives and future directions
    15. Translating smart biosensors for metabolic health: Regulatory pathways, ethical governance and commercialization strategy